Artificial Intelligence

Sword Health expands its Bloom platform, using AI to offer continuous support for women from fertility to menopause and challenge the fragmented healthcare system.

With data from 150M patients, SEQSTER's new platform promises to accelerate drug development, improve trial diversity, and make research-ready data a reality.

With a 373% revenue spike and key hires, AI platform Hebbia is rapidly moving from experiment to essential tool for Europe's top financial firms.

Scaled Agile's annual summit pivots to AI, unveiling new research on AI's economic reality and a roadmap for enterprises to become truly 'AI-Native'.

A new industry-first model allows health plans to pay only for successful HEDIS gap closures, eliminating financial risk amid rising quality pressures.

Top exec search firm Christian & Timbers moves from placing leaders to deploying AI, launching a new arm to deliver measurable ROI with Agentic systems.

As AI adoption outpaces oversight, Check Point’s new advisory service aims to help enterprises manage risk and navigate complex new regulations like the EU AI Act.

The firm's new Google Cloud honors signal a major push in AI-driven government services, promising to reshape how citizens interact with public agencies.

The market data provider's new ISO/IEC 27001:2022 certification signals a new era of trust and resilience in the high-stakes world of financial data.

As AI enters the courtroom, a Legalweek panel tackles the agentic and generative tech transforming complex cases and the urgent ethical dilemmas that follow.

As AI-generated code introduces new risks, Snyk's partner awards highlight a channel-first strategy to tackle the 'speed paradox' in software security.

At MWC26, iFLYTEK launched ambitious AI translation glasses, but faces stiff competition from Google and Alibaba, along with lingering privacy questions.

The Bloomberg 500 adds 11 tech-heavy firms like Nebius Group and ASTS, signaling a major shift in market leadership driven by AI and digital infrastructure.

With a major new investment, Cognito Therapeutics is pushing its non-invasive light and sound therapy for Alzheimer's toward a 2027 market launch.

A new acquisition in data center alley reveals how investors are profiting from the AI boom by betting on the crucial, but overlooked, support infrastructure.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

A new survey finds AI makes procurement teams 3.7x more resilient, yet many leaders are held back by a dangerous overconfidence in their own knowledge.

A new FDA program offers a lifeline for patients with rare ROSAH syndrome, accelerating Drug Farm's promising first-in-class therapy.

Asia's top tech expo unveils its 2026 theme, focusing on AI's leap from code to robotics, wearables, and smart systems, cementing the region's global role.

A new Chinese fantasy drama personifies ancient instruments into living spirits. Here's how 'The Melody of Love' is set to change global entertainment.